Are coupons that help patients afford their co-pays a help – or a hindrance – in the age of innovative but costly prescription medications? A
By Stuart Isaacson, MD Most all of us know someone living in a long-term care facility – a friend, a former neighbor, a family member.
Nearly one in five Americans with hepatitis C spends time behind bars each year, making the prison system an opportune environment to test and cure
Accessing innovative cardiovascular drugs may soon get harder. A new publication from the Institute for Clinical and Economic Review, a drug price analysis group, assigns
Physician organization urges the Senate to reauthorize the bill before leaving for August recess WASHINGTON – The Alliance for Patient Access (AfPA) made the following statement
Health plans are embracing biosimilars, a new Avalere Health study reveals. Eighty-one percent of health plans now cover at least one of the two biosimilars
Long-awaited treatment for a movement disorder known as tardive dyskinesia could remain out of reach – unless an upcoming cost-effectiveness analysis acknowledges its value to
Some wore shades, others “showed purple.” But advocates across the board used June’s Migraine & Headache Awareness Month to draw attention to a condition whose